Price Alert

Medpace Inc. (MEDP)

NASDAQ: MEDP · Real-Time Price · USD

458.44

-9.56 (-2.04%)

At close: Aug 14, 2025, 3:59 PM

455.50

-0.64%

After-hours: Aug 14, 2025, 05:04 PM EDT

Medpace Statistics

Share Statistics

Medpace has 28.09M shares outstanding. The number of shares has increased by -7.29% in one year.

Shares Outstanding	28.09M
Shares Change (YoY)	-7.29%
Shares Change (QoQ)	-5.66%
Owned by Institutions (%)	83.25%
Shares Floating	22.7M
Failed to Deliver (FTD) Shares	20
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 3.06M, so 10.89% of the outstanding shares have been sold short.

Short Interest	3.06M
Short % of Shares Out	10.89%
Short % of Float	13.78%
Short Ratio (days to cover)	9.04

Valuation Ratios

The PE ratio is 25.43 and the forward PE ratio is 28.05. Medpace's PEG ratio is 0.61.

PE Ratio	25.43
Forward PE	28.05
PS Ratio	4.88
Forward PS	4.8
PB Ratio	12.46
P/FCF Ratio	17.97
PEG Ratio	0.61

Financial Ratio History

Enterprise Valuation

Medpace has an Enterprise Value (EV) of 9.76B.

EV / Sales	4.63
EV / EBITDA	20.51
EV / EBIT	16.04
EV / FCF	17.06

Financial Position

The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.18.

Current Ratio	0.93
Quick Ratio	0.93
Debt / Equity	0.18
Debt / EBITDA	0.31
Debt / FCF	0.26
Interest Coverage	0

Financial Efficiency

Return on Equity is 48.98% and Return on Invested Capital is 37.24%.

Return on Equity	48.98%
Return on Assets	19.25%
Return on Invested Capital	37.24%
Revenue Per Employee	$357.47K
Profits Per Employee	$68.54K
Employee Count	5,900
Asset Turnover	1
Inventory Turnover	n/a

Taxes

Income Tax	71.54M
Effective Tax Rate	15.03%

Stock Price Statistics

The stock price has increased by 19.66% in the last 52 weeks. The beta is 1.43, so Medpace's price volatility has been higher than the market average.

Beta	1.43
52-Week Price Change	19.66%
50-Day Moving Average	346.5
200-Day Moving Average	331.67
Relative Strength Index (RSI)	63.69
Average Volume (20 Days)	495,625

Income Statement

In the last 12 months, Medpace had revenue of 2.11B and earned 404.39M in profits. Earnings per share was 13.06.

Revenue	2.11B
Gross Profit	656.3M
Operating Income	446.87M
Net Income	404.39M
EBITDA	476.12M
EBIT	446.87M
Earnings Per Share (EPS)	13.06

Full Income Statement

Balance Sheet

The company has 669.44M in cash and 149.52M in debt, giving a net cash position of 519.91M.

Cash & Cash Equivalents	669.44M
Total Debt	149.52M
Net Cash	519.91M
Retained Earnings	8.17M
Total Assets	1.57B
Working Capital	-699.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 608.82M and capital expenditures -36.55M, giving a free cash flow of 572.27M.

Operating Cash Flow	608.82M
Capital Expenditures	-36.55M
Free Cash Flow	572.27M
FCF Per Share	18.49

Full Cash Flow Statement

Margins

Gross margin is 31.12%, with operating and profit margins of 21.19% and 19.17%.

Gross Margin	31.12%
Operating Margin	21.19%
Pretax Margin	22.57%
Profit Margin	19.17%
EBITDA Margin	22.58%
EBIT Margin	21.19%
FCF Margin	27.13%

Dividends & Yields

MEDP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	3.93%
FCF Yield	5.56%

Dividend Details

Analyst Forecast

The average price target for MEDP is $430, which is -4.4% lower than the current price. The consensus rating is "Hold".

Price Target	$430
Price Target Difference	-4.4%
Analyst Consensus	Hold
Analyst Count	10

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$326.5
Lynch Upside	-27.4%
Graham Number	88.53
Graham Upside	-80.31%

Scores

Altman Z-Score	6.49
Piotroski F-Score	6